Sort
10,766 grants matching “checkpoint inhibitor”
Discovery of Glutaryl-CoA Dehydrogenase inhibitors for melanoma and pancreatic cancer
$538,890Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA
Systems Biology of Glycosylation
$538,813Sriram Neelamegham · State University Of New York At Buffalo · R01 · FY2024 · HL
Targeting PIM-2 Kinase for Improving Cancer Immunotherapy
$538,665Xue-Zhong Yu · Medical College Of Wisconsin · R01 · FY2025 · CA
Kinetic Assembly of Polymer-mRNA Nanoparticles Targets Circulating Monocytes to Enhance Cancer Immunotherapy
$538,330Hai-Quan Mao · Johns Hopkins University · R01 · FY2024 · CA
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy
$537,921Zihai Li · Ohio State University · R01 · FY2023 · CA
Epigenetic and immunologic aspects of neuroendocrine cancers
$537,880Nitin Roper · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Studies of Materials with Physiological Properties
$537,858Harvard University · R01 · FY2002 · GM
Chemotherapy and the Bladder Cancer Immune Microenvironment
$537,831William Y Kim · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
UCSF Project 1
$537,768Trever G Bivona · University Of California, San Francisco · U54 · FY2020 · CA
Sustaining Tissue Resident Memory T cells
$537,503Yina Hsing Huang · Dartmouth College · R01 · FY2022 · CA
Sustaining Tissue Resident Memory T cells
$537,503Yina Hsing Huang · Dartmouth College · R01 · FY2025 · CA
Project 1: Evaluating stem-like T cells and improving efficacy of checkpoint inhibitors in NSCLC
$537,336Rafi Ahmed · Emory University · P50 · FY2022 · CA
Evaluation of Novel Radiation Modifiers
$537,232Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Plk1 as a prognostic biomarker for prostate cancer
$537,065Xiaoqi Liu · University Of Kentucky · R01 · FY2023 · CA
Plk1 as a prognostic biomarker for prostate cancer
$537,065Xiaoqi Liu · University Of Kentucky · R01 · FY2022 · CA
Targeting myeloid suppression to enhance anti-tumor immunity in breast cancer
$536,866Evanthia Theodosiou Roussos Torres · University Of Southern California · R01 · FY2024 · CA
Development of a novel therapy targeting the tumor microenvironment in inflammatory breast cancer
$536,764Naoto T Ueno · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Functional and Therapeutic Significance of PLK4 in Melanoma
$536,631Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2023 · CA
Immunogenomic predictors of outcomes in patients with locally advanced cervical cancer treated with immunotherapy and chemoradiation
$536,602Dmitriy Zamarin · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer
$536,528Bryan Quilty Spring · Northeastern University · U01 · FY2025 · CA
Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironment
$536,018Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Role of PI3Kgamma in Tumor Progression and Metastasis
$535,870Judith A. Varner · University Of California, San Diego · R01 · FY2023 · CA
Role of PI3Kgamma in Tumor Progression and Metastasis
$535,870Judith A. Varner · University Of California, San Diego · R01 · FY2025 · CA
Investigating a new vulnerability in oral squamous cell carcinoma
$535,846Christine M Eischen · Thomas Jefferson University · R01 · FY2023 · DE
Project 1- Elucidating oncogenic KRAS in PDAC cell signaling, resistance and immunity
$535,816Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2022 · CA